Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenoldopam mesilate to control splanchnic ischemia during cardiopulmonary bypass in pediatric patients
2009-009115-22Phase 2Active
- Sponsor
- Istituto Giannina Gaslini
- Start
- Mar 2009
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of fenoldopam in Cardiovascular Malformation (CVM), sponsored by Istituto Giannina Gaslini. Primary endpoint: Primary endpoint: lactate level at end of cardiopulmonary bypass. Started Mar 2009; status: active.
02
Drugs
fenoldopam
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on 2009-009115-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009115-22.